Cyfuse Biomedical K.K. (TYO:4892)
Japan
· Delayed Price · Currency is JPY 977.00
-5.00 (-0.51%)
Apr 28, 2025, 3:30 PM JST
Cyfuse Biomedical K.K. Revenue
In the year 2024, Cyfuse Biomedical K.K. had annual revenue of 54.00M JPY, down -11.48%. Cyfuse Biomedical K.K. had revenue of 28.00M in the quarter ending December 31, 2024, a decrease of -12.50%.
Revenue
54.00M
Revenue Growth
-11.48%
P/S Ratio
142.83
Revenue / Employee
2.57M
Employees
21
Market Cap
7.71B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Daiichi Sankyo Company | 1,795.99B |
| Takeda Pharmaceutical Company | 4,579.02B |
| HOYA Corporation | 838.60B |
| Terumo | 1,011.15B |
| Otsuka Holdings | 2,329.86B |
| Astellas Pharma | 1,867.63B |
| Olympus | 993.33B |